By: Benzinga
February 22, 2013 at 13:40 PM EST
UPDATE: Oppenheimer Reiterates Perform Rating, Raises PT on DexCom on 4Q12 Revenues
In a report published Friday, Oppenheimer reiterated its Perform rating on DexCom (NASDAQ: DXCM ), and slightly raised its price target from $14.00 to $15.00. Oppenheimer noted, “DexCom's 4Q12 revenues of $33M included $31.7M in product revenues (in line with pre-announcement). Management reiterated 2013 product revenue guidance of $120-130M. The
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here